Heath Lukatch

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
San Carlos, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
Heath Lukatch, by /s/ Peter N. Efremenko, Attorney-In-Fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Heath Lukatch

Form 4 holding Director

Inogen Inc

Security class
Common Stock
Shares / value
12,775
Estimated value
$73,073
Report date
10 May 2021
Price
$5.72
Ownership
Direct
Form 4 holding Director

Vaxcyte, Inc.

Security class
Stock Option (right to buy)
Shares / value
11,389
Estimated value
Report date
15 Jun 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Flexion Therapeutics Inc

Security class
Stock option (right to buy)
Shares / value
0
Estimated value
Report date
19 Nov 2021
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Satsuma Pharmaceuticals, Inc.

Security class
Stock Option (right to buy)
Shares / value
0
Estimated value
Report date
08 Jun 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Heath Lukatch

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .